KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Gross Margin (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Gross Margin for 7 consecutive years, with 200.29% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 26702.0% to 200.29% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 92.77% through Dec 2025, up 3911.0% year-over-year, with the annual reading at 92.77% for FY2025, 3911.0% up from the prior year.
  • Gross Margin hit 200.29% in Q4 2025 for GoodRx Holdings, up from 57.39% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 200.29% in Q4 2025 to a low of 66.73% in Q4 2024.
  • Historically, Gross Margin has averaged 70.4% across 5 years, with a median of 58.28% in 2025.
  • Biggest five-year swings in Gross Margin: plummeted -11905bps in 2024 and later soared 26702bps in 2025.
  • Year by year, Gross Margin stood at 50.06% in 2021, then increased by 8bps to 54.31% in 2022, then fell by -4bps to 52.32% in 2023, then plummeted by -228bps to 66.73% in 2024, then skyrocketed by 400bps to 200.29% in 2025.
  • Business Quant data shows Gross Margin for GDRX at 200.29% in Q4 2025, 57.39% in Q3 2025, and 58.21% in Q2 2025.